The most common side effects of GLP-1 drugs are gastrointestinal, such as nausea, vomiting, and diarrhea
Abel, Circ
Three groups were identified: participants with current MDD (that is, participants meeting DSM-IV criteria for MDD within the past 6 months), with remitted (i.e., lifetime but not current) MDD, and healthy controls (without any lifetime depressive/anxiety disorder)
GLP-1 medications are FDA-approved for specific indications, and eligibility is determined by a licensed clinician
a mediation analysis estimated that only approximately one third of the MACE benefit was attributable to waist-circumference reduction, indicating substantial weight-independent benefit [34], [35]
Not for therapeutic, diagnostic, or veterinary use.